4D Molecular Therapeutics, Inc.
FDMT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in 4D Molecular Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 140
- −2 vs. Q2 2024
- Shares held
- 58.2M
- +5.80M (+11.1%) vs. Q2 2024
- Total value
- $629.2M
- −$472.2M (−42.9%) vs. Q2 2024
- New holders
- 23
- 57 more added
- Sold out
- 25
- 43 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FDMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $771.2M |
| Q1 2026 | 153 | $471.4M |
| Q4 2025 | 153 | $400.5M |
| Q3 2025 | 134 | $343.2M |
| Q2 2025 | 121 | $149.9M |
| Q1 2025 | 126 | $139.8M |
| Q4 2024 | 146 | $260.6M |
| Q3 2024 | 140 | $629.2M |
| Q2 2024 | 143 | $1.20B |
| Q1 2024 | 147 | $1.79B |
| Q4 2023 | 111 | $859.8M |
| Q3 2023 | 110 | $533.6M |
| Q2 2023 | 100 | $745.3M |
| Q1 2023 | 94 | $522.3M |
| Q4 2022 | 96 | $621.9M |
| Q3 2022 | 88 | $210.4M |
| Q2 2022 | 90 | $181.7M |
| Q1 2022 | 80 | $395.3M |
| Q4 2021 | 77 | $541.8M |
| Q3 2021 | 63 | $515.1M |
| Q2 2021 | 56 | $400.0M |
| Q1 2021 | 64 | $664.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding 4D Molecular Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 127,648 | $1.38M | 0.00% | +54,450+74.4% | Added |
| Jane Street Group, LLC | 145,512 | $1.57M | 0.00% | +11,987+9.0% | Added |
| Perigon Wealth Management, LLC | 146,170 | $1.58M | 0.04% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 146,405 | $1.58M | 0.00% | −23,008−13.6% | Reduced |
| Qube Research & Technologies Ltd | 161,296 | $1.74M | 0.00% | +74,840+86.6% | Added |
| Marshall Wace, LLP | 165,193 | $1.79M | 0.00% | −20,673−11.1% | Reduced |
| Wellington Management Group LLP | 166,190 | $1.80M | 0.00% | −13,254−7.4% | Reduced |
| Dimensional Fund Advisors LP | 208,815 | $2.26M | 0.00% | −323,927−60.8% | Reduced |
| Bank of America Corp | 268,856 | $2.91M | 0.00% | +41,257+18.1% | Added |
| Voloridge Investment Management, LLC | 290,031 | $3.14M | 0.01% | −71,666−19.8% | Reduced |
| JPMorgan Chase & Co | 315,983 | $3.42M | 0.00% | −29,790−8.6% | Reduced |
| Armistice Capital, LLC | 336,000 | $3.63M | 0.09% | +336,000 | New |
| Charles Schwab Investment Management Inc | 338,317 | $3.66M | 0.00% | +452+0.1% | Added |
| Kennedy Capital Management, Inc. | 351,653 | $3.80M | 0.08% | +174,888+98.9% | Added |
| Decheng Capital LLC | 397,835 | $4.30M | 1.02% | +50,000+14.4% | Added |
| Eventide Asset Management, LLC | 422,856 | $4.57M | 0.08% | −458,301−52.0% | Reduced |
| Northern Trust Corp | 430,683 | $4.66M | 0.00% | +63,204+17.2% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 459,000 | $4.96M | 0.01% | −247,000−35.0% | Reduced |
| Eagle Health Investments LP | 462,911 | $5.00M | 0.96% | 00.0% | Unchanged |
| Norges Bank | 524,711 | $5.67M | 0.00% | +524,711 | New |
| Deutsche Bank AG | 802,637 | $8.68M | 0.00% | +678,298+545.5% | Added |
| ArrowMark Colorado Holdings LLC | 803,490 | $8.69M | 0.11% | −46,711−5.5% | Reduced |
| Polar Capital Holdings Plc | 838,492 | $9.06M | 0.05% | −906,365−51.9% | Reduced |
| Geode Capital Management, LLC | 1,036,545 | $11.2M | 0.00% | −24,346−2.3% | Reduced |
| Casdin Capital, LLC | 1,150,000 | $12.4M | 0.83% | +350,000+43.8% | Added |
| Braidwell LP | 1,225,448 | $13.2M | 0.38% | +855,990+231.7% | Added |
| Redmile Group, LLC | 1,262,090 | $13.6M | 0.80% | +188,655+17.6% | Added |
| Novo Holdings A/S | 1,500,000 | $16.2M | 0.81% | +100,000+7.1% | Added |
| Assenagon Asset Management S.A. | 1,543,414 | $16.7M | 0.03% | +1,087,147+238.3% | Added |
| Morgan Stanley | 1,702,339 | $18.4M | 0.00% | +242,105+16.6% | Added |
| State Street Corp | 2,116,508 | $22.9M | 0.00% | +37,232+1.8% | Added |
| Vanguard Group Inc | 2,767,717 | $29.9M | 0.00% | +239,537+9.5% | Added |
| Janus Henderson Group PLC | 3,137,087 | $33.9M | 0.02% | −59,675−1.9% | Reduced |
| Goldman Sachs Group Inc | 3,591,030 | $38.8M | 0.01% | −543,224−13.1% | Reduced |
| Deep Track Capital, LP | 4,096,452 | $44.3M | 1.41% | +35,051+0.9% | Added |
| VR Adviser, LLC | 4,400,000 | $47.6M | 2.49% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,868,789 | $52.6M | 0.00% | +4,868,789 | New |
| Ra Capital Management, L.P. | 5,098,211 | $55.1M | 0.64% | 00.0% | Unchanged |
| BVF Inc | 7,382,642 | $79.8M | 2.33% | +3,460,229+88.2% | Added |
| DekaBank Deutsche Girozentrale | 30,000 | – | – | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 0 | $0 | 0.00% | −2,934,914−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −345,750−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −271,155−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −138,800−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −108,598−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −49,945−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −39,415−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −39,356−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −28,385−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −21,034−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −15,578−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −15,532−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,273−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −11,079−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −10,171−100.0% | Sold out |
| Elmwood Wealth Management, Inc. | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −9,548−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,065−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −544−100.0% | Sold out |
| BFSG, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |